SecBot SecBot

RCUS

Arcus Biosciences, Inc.
NYSE· Pharmaceutical Preparations· Inc. DE· CIK 0001724521 Biotech & Drug Discovery
$16.86 −0.57 (−3.27%)
Nov 16 4:00 PM ET · prev $17.43
Market cap
$2.6B
Mid cap
Consensus
Buy
86% Buy or better · 21 analysts
Median target
🔒 Subscribers only
1 year
−15.7%
from $19.99 · Nov 17
30 days
−23.8%
from $22.14
52-week range
$16.86–31.57
at the low
Avg volume 20D
2.53M
Oct 22 spike 8.37M
Short interest
13.18M
≈9.2% of shares · +6.6%
Days to cover
3.6
at average volume
Insider net
−$3.3M
0 buyers · 3 sellers · 12 mo
New fund stakes
2
Q3 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BEARISH 8 reports · 90 days
Balance 3 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 3/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders sold $3.3M.

  • InstitutionsBULLISH

    Q3 2026: 26 added (2 new), 12 trimmed or exited. Largest new: Loomis Sayles & L P $19.1M, Panagora Asset Management $12.1M.

  • AnalystsBULLISH

    18 of 21 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +6.6% to 13.18M shares. 3.6 days to cover, ≈9.2% of shares.

  • TrendDOWNTREND

    25% below its 50-day average. New closing low $16.86 on Nov 16.

Who's buying

13F· Q3 2026
2
new positions
0
exits
$31.2M
in new stakes
FundMoveSharesValue
Invesco Ltd.ADD1,184,953$30.6M
MORGAN STANLEYADD1,165,831$30.1M
Aberdeen Group plcADD1,056,679$27.3M
JPMORGAN CHASE & COADD765,041$19.7M
LOOMIS SAYLES & CO L PNEW741,283$19.1M
UBS Group AGADD665,892$17.2M
PANAGORA ASSET MANAGEMENT INCNEW467,340$12.1M
FIRST TRUST ADVISORS LPADD460,504$11.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

21 analysts
Buy 86% rate it Buy or better
Strong Buy6Buy12Hold3Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 5, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Nov 5, 2026Wedbush
MAINTAIN
MAINTAINOutperform
Oct 21, 2026Citigroup
MAINTAIN
MAINTAINBuy
Oct 21, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Oct 21, 2026Wedbush
MAINTAIN
MAINTAINOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$3.3M
sold · 3 insiders
DateInsiderTypeValue
Aug 21, 2026
Azoy Alexander
Chief Accounting Officer
Aug 21, 2026
EXERCISE$43.6K
Aug 21, 2026
Azoy Alexander
Chief Accounting Officer
Aug 21, 2026
SELL$84.8K
Jul 10, 2026
Jaen Juan C.
President
Jul 10, 2026
SELL$7.9K
Jul 10, 2026
Jaen Juan C.
President
Jul 10, 2026
SELL$566.4K
Jul 9, 2026
Jaen Juan C.
President
Jul 9, 2026
SELL$1.5M
Jun 24, 2026
Jaen Juan C.
President
Jun 24, 2026
SELL$190.7K
Jun 23, 2026
Jaen Juan C.
President
Jun 23, 2026
SELL$389.5K
Jun 23, 2026
Jaen Juan C.
President
Jun 23, 2026
SELL$47.6K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q-$0.88-$1.00–-$0.78+3.7%$6.0M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
13,177,876
shares short
+6.6%
vs prior settlement
3.6
days to cover
≈9.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 9, 2026 SEC
Five institutional investors added $9.8M in RCUS during Q3 2026, led by Aberdeen Group doubling its stake to $27.3M…
INST-CLUSTER · Impact 3/10
Nov 4, 2026 SEC
The company highlighted strong clinical data for its lead candidate casdatifan and extended its cash runway into 2029…
8-K · Impact 5/10
Nov 4, 2026 Earnings result
RCUS Q3 2026 Earnings: EPS $-1 (-9.4% vs est)
Sep 30, 2026 Inst.
Invesco Ltd. · ADD
1,184,953 shares ($30.6M)
Sep 30, 2026 Inst.
MORGAN STANLEY · ADD
1,165,831 shares ($30.1M)
Aug 21, 2026 Insider
Azoy Alexander acquired via exercise 2,827 shares
Chief Accounting Officer @ $15.44 ($43.6K)
Aug 21, 2026 Insider
Azoy Alexander sold 2,827 shares
Chief Accounting Officer @ $30.00 ($84.8K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
5 drugs tracked · Drug pipeline →
Recent

SecBot reports

13 filings · 0 bullish · 4 bearish · 1 mixed · 8 neutral
All RCUS filing & press-release reports (13)